
Twitch to Exit South Korea in 2024 Amid High Costs and Video Quality Issues
Dec 06, 2023 08:43 am UTC| Business Technology
Twitch, the popular video streaming service, announced that it will shut down its operations in South Korea next year. Despite its previous dominance in the South Korean gaming market, Twitch has been grappling with high...

Dec 06, 2023 07:49 am UTC| Business
Elon Musks recent endorsement of an antisemitic conspiracy theory on X (formerly Twitter) is the latest in a series of controversial statements the owner of the social media platform has made since he acquired it in 2022....

Dec 06, 2023 07:46 am UTC| Technology Business
When it comes to accessibility in gaming, Microsoft takes two steps forward with the Xbox Adaptive Controller, but a giant leap back with its ban on third-party devices. On Oct. 31, some Xbox players began receiving a...

ATP and Lacoste Renew Partnership, Uniting Tennis and Fashion for 2024-2026
Dec 06, 2023 07:12 am UTC| Business Sports
ATP extended its longstanding partnership with Lacoste, the renowned fashion-sport brand. Lacoste will retain its position as the Official Outfitter of the ATP Tour for 2024-2026. As part of this partnership, Lacoste...

GTA 6: Grand Theft Auto VI Leak Forced Rockstar Games to Release Trailer Early
Dec 06, 2023 06:55 am UTC| Business
Rockstar Games finally dropped the official trailer for the sixth installment of its popular game title, Grand Theft Auto. However, the video game companys original schedule for the release was not followed. Rockstar...

JM Smucker Surges on Profits, Acquires Hostess, Eyes Growth Amid Market Challenges
Dec 06, 2023 06:42 am UTC| Business
J.M. Smucker, the parent company of Jif peanut butter and Dunkin pre-made coffee, surpassed profit expectations in the second quarter. The Ohio-based company benefited from increased product pricing and reduced input...

Merck KGaA's Evobrutinib Falls Short in Multiple Sclerosis Trials
Dec 06, 2023 06:21 am UTC| Business Health
Merck KGaA, a leading pharmaceutical company based in Germany, announced that its experimental multiple sclerosis (MS) drug, evobrutinib, did not meet the primary goal in highly anticipated late-stage trials. The failure...